Opening book details…
About this Medicine article
Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study'' by Shinozaki, Eiji; Yoshino, Takayuki; Tsuchihara, Katsuya is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Shinozaki, Eiji; Yoshino, Takayuki; Tsuchihara, Katsuya
- Publisher
- Nature Publishing Group; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0007-0920)
- Published
- 2018
- Field
- Medicine (Health Sciences)